Yoshiji Hantani

Identification and Characterization of a Novel Chemotype MEK Inhibitor Able to Alter the Phosphorylation State of MEK1/2

Takayuki Yoshida, Junya Kakegawa, Takayuki Yamaguchi et al. · Oncotarget · 2012 · 59 citations · Full text

Chemoprevention Strategy, Tumor Biology, Molecular Pharmacology +19

New Class of Corticotropin-Releasing Factor (CRF) Antagonists:  Small Peptides Having High Binding Affinity for CRF Receptor

Yasuki Yamada, Kenji Mizutani, Yasuhiro Mizusawa et al. · Journal of Medicinal Chemistry · 2004 · 28 citations · Full text

Small Peptide, Peptide Science, Hypothalamic Peptide +18

Identification of an Arginase II Inhibitor via RapidFire Mass Spectrometry Combined with Hydrophilic Interaction Chromatography

Wataru Asano, Yu Takahashi, Motoaki Kawano et al. · SLAS DISCOVERY · 2018 · 22 citations · Full text

Symmetry-based ligand design and evaluation of small molecule inhibitors of programmed cell death-1/programmed death-ligand 1 interaction

Seiji Kawashita, Koichi Aoyagi, Hiroshi Yamanaka et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 21 citations · Full text

Small Molecule Inhibitors, Medicinal Chemistry, Ligand-based Drug Design +14

Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1–Nrf2 PPI Inhibitor

Kazuki Otake, Minoru Ubukata, Noboru Nagahashi et al. · ACS Medicinal Chemistry Letters · 2023 · 20 citations · Full text